In GBM, multiple metabolic signals control Myc expression, which, in turn, governs the activation of cancer metabolic routes and the shunting from one pathway to another (Figure 3), suggesting a Myc-centered, self-sustaining metabolic circuit fulfilling GBM cell and, more importantly, GSC energy demand, fostering tumor growth. The gene discussed is MYC; the disease is glioblastoma.